IOBT IO Biotech, Inc.
Healthcare$0.01+0.00%OpenMarket Cap: $885,690
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$0.50
Target (Median)
$0.50
Target Range
$0.50 - $0.50
Upside from current price: 3961.7%
Rating Distribution
0 Strong Buy1 Buy2 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-01-26 | Piper Sandler | downgrade | Neutral | Overweight |
| 2025-10-22 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-09-30 | TD Cowen | downgrade | Hold | Buy |
| 2025-09-29 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-08-12 | Morgan Stanley | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.31 | $17.8M | 1 |
| Sun Dec 31 | $-0.19 | $54.1M | 2 |
| Mon Dec 31 | $-0.04 | $145.9M | 1 |
| Tue Dec 31 | $-0.04 | $212.2M | 1 |